Lavaca Capital LLC Bristol Myers Squibb CO Transaction History

Lavaca Capital LLC

$233 Million
Q3 2024

A detailed history of Lavaca Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lavaca Capital LLC holds 4,545 shares of BMY stock, worth $269,382. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,545

Holding current value

$269,382

% of portfolio

0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $180,254 - $235,203	4,545 New	4,545 $235,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $14,154 - $16,048	295 Added 7.2%	4,395 $238,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $5,817 - $6,942	-120 Reduced 2.84%	4,100 $210,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $10,478 - $11,716	-181 Reduced 4.11%	4,220 $244,000
Q2 2023 Aug 25, 2023	BUY	$63.71 - $70.74 $280,387 - $311,326	4,401 New	4,401 $281,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $19,712 - $22,359	-300 Reduced 5.5%	5,153 $357,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $8,696 - $10,298	-127 Reduced 2.28%	5,453 $392,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $39 - $23,052	300 Added 5.68%	5,580 $400,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $7,625 - $8,397	-105 Reduced 1.95%	5,280 $405,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $331,069 - $396,982	5,385 New	5,385 $393,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $351,215 - $382,473	-5,673 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $157,251 - $176,861	-2,650 Reduced 31.84%	5,673 $358,000
Q4 2020 Jan 13, 2021	SELL	$57.74 - $65.43 $635 - $719	-11 Reduced 0.13%	8,323 $516,000
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $478,621 - $530,375	8,334 New	8,334 $502,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $236,593 - $343,825	-5,099 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $23,423 - $30,554	-476 Reduced 8.54%	5,099 $327,000
Q3 2019 Nov 04, 2019	BUY	$42.77 - $50.71 $238,442 - $282,708	5,575 New	5,575 $283,000
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $191,598 - $211,865	-4,294 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$45.12 - $53.8 $83,562 - $99,637	1,852 Added 75.84%	4,294 $205,000
Q4 2018 Jan 22, 2019	BUY	$48.76 - $63.23 $119,071 - $154,407	2,442 New	2,442 $127,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.2 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.4 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.51 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.62 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.62 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lavaca Capital LLC with notifications on news.

Account